Largest biotech by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Gilead Sciences leads the 24 biotech ranked by earnings, at DKK 58B, ahead of Amgen (DKK 52.5B) and Biogen (DKK 8.8B). Figures as of 18 Nov 2026, 15:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Gilead SciencesDKK 58B
- Median
- -DKK 467.4M
- Combined market value
- DKK 5.77T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead SciencesGILD · Health Care | DKK 58B | DKK 1.43T | DKK 1,152.81 | 0.65% down | 33% up | ||
| 2 | AmgenAMGN · Health Care | DKK 52.5B | DKK 1.66T | DKK 3,069.64 | 1.64% down | 34% up | ||
| 3 | BiogenBIIB · Health Care | DKK 8.8B | DKK 252.1B | DKK 1,705.70 | 0.20% down | 49% up | ||
| 4 | argenxARGX · Health Care | DKK 8.8B | DKK 411.9B | DKK 6,549.54 | 1.43% up | 4% up | ||
| 5 | ExelixisEXEL · Health Care | DKK 5.3B | DKK 115B | DKK 471.32 | 0.96% up | 63% up | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | DKK 3.3B | DKK 112.7B | DKK 1,112.94 | 1.57% down | 20% up | ||
| 7 | QiagenQGEN · Health Care | DKK 2.9B | DKK 69.9B | DKK 338.43 | 0.18% down | 12% up | ||
| 8 | Halozyme TherapeuticsHALO · Health Care | DKK 2.2B | DKK 75.5B | DKK 662.24 | 1.26% up | 37% up | ||
| 9 | Krystal BiotechKRYS · Health Care | DKK 1.4B | DKK 62.5B | DKK 2,108.53 | 3.63% up | 46% up | ||
| 10 | Bio-TechneTECH · Health Care | DKK 1.2B | DKK 77.8B | DKK 495.45 | 0.10% up | 26% up | ||
| 11 | RepligenRGEN · Health Care | DKK 333.2M | DKK 75.1B | DKK 1,174.72 | 6.29% up | 5% up | ||
| 12 | Adaptive BiotechnologiesADPT · Health Care | -DKK 405.5M | DKK 31.8B | DKK 196.50 | 1.21% up | 88% up | ||
| 13 | Twist BioscienceTWST · Health Care | -DKK 529.3M | DKK 54.5B | DKK 799.80 | 4.79% up | 340% up | ||
| 14 | CG OncologyCGON · Health Care | -DKK 1.1B | DKK 48.3B | DKK 540.42 | 0.46% up | 85% up | ||
| 15 | Kodiak SciencesKOD · Health Care | -DKK 1.6B | DKK 44.2B | DKK 676.07 | 2.48% up | 396% up | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | -DKK 2.1B | DKK 71.7B | DKK 839.39 | 1.36% up | 87% up | ||
| 17 | ImmunityBioIBRX · Health Care | -DKK 2.4B | DKK 48.1B | DKK 45.25 | 6.07% up | 193% up | ||
| 18 | Scholar Rock HoldingSRRK · Health Care | -DKK 2.6B | DKK 40.3B | DKK 330.18 | 7.48% up | 14% up | ||
| 19 | ImmunovantIMVT · Health Care | -DKK 3.4B | DKK 47.8B | DKK 231.09 | 2.11% up | 43% up | ||
| 20 | CRISPR TherapeuticsCRSP · Health Care | -DKK 4B | DKK 27.6B | DKK 284.39 | 3.94% up | 21% down | ||
| 21 | VaxcytePCVX · Health Care | -DKK 5.2B | DKK 63.8B | DKK 402.76 | 0.51% down | 22% up | ||
| 22 | Revolution MedicinesRVMD · Health Care | -DKK 7.7B | DKK 238.5B | DKK 1,102.72 | 0.54% down | 131% up | ||
| 23 | BioNTechBNTX · Health Care | -DKK 8.6B | DKK 143.6B | DKK 579.13 | 0.14% up | 16% down | ||
| 24 | ModernaMRNA · Health Care | -DKK 19.2B | DKK 568.9B | DKK 1,406.12 | 0.23% down | 755% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8149 DKK).
Questions and answers
Which biotech rank first by earnings?
Gilead Sciences (DKK 58B), Amgen (DKK 52.5B) and Biogen (DKK 8.8B) are the top three of the 24 biotech ranked by earnings as of 18 Nov 2026, 15:14 UTC.
How many biotech are in this ranking?
24 are ranked by earnings.
What are these biotech worth together?
The 24 biotech ranked by earnings have a combined market value of DKK 5.77T as of 18 Nov 2026, 15:14 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.